Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
IMAC HoldingsBACK 3-Year EPS without NRI Growth Rate is 24.40% as of Sep. 2025, which is 130% above its 10-year median of 10.60. The stock has 7 warning signs investors should review. Among 507 Healthcare Providers & Services companies, IMAC Holdings ranks better than 66.27% on this metric.
During the past 3 years, the average EPS without NRI Growth Rate was 24.40% per year.
During the past 5 years, the average EPS without NRI Growth Rate was 32.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
During the past 9 years, the highest 3-Year average EPS without NRI Growth Rate of IMAC Holdings was 47.60% per year. The lowest was -331.50% per year. And the median was 10.60% per year.
IMAC Holdings (OTCPK:BACK) 3-Year EPS without NRI Growth Rate Explanation
EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.
IMAC Holdings 3-Year EPS without NRI Growth Rate Related Terms
BACK vs MSPR, HCA, THC: 3-Year EPS without NRI Growth Rate Comparison
For the Medical Care Facilities subindustry, IMAC Holdings's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IMAC Holdings 3-Year EPS without NRI Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, IMAC Holdings's 3-Year EPS without NRI Growth Rate distribution charts can be found below:
* The bar in red indicates where IMAC Holdings's 3-Year EPS without NRI Growth Rate falls into.
IMAC Holdings 3-Year EPS without NRI Growth Rate Calculation
This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
What does a 3-Year EPS without NRI Growth Rate of 24.40% mean?
IMAC Holdings (BACK) has a 3-Year EPS without NRI Growth Rate of 24.40% as of Sep. 2025. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for IMAC Holdings and its competitors. This is 130% above median its historical median of 10.60. According to the industry distribution chart, IMAC Holdings ranks #171 out of 507 companies in the Healthcare Providers & Services industry, placing it in the top 33.7%.
Is IMAC Holdings' 3-Year EPS without NRI Growth Rate too high?
IMAC Holdings' current 3-Year EPS without NRI Growth Rate of 24.40% is 130% above median its 10-year median of 10.60. The Healthcare Providers & Services industry median 3-Year EPS without NRI Growth Rate is 11.30. IMAC Holdings' value of 24.40% is 115.9% above this industry median. Based on the distribution chart, IMAC Holdings ranks #171 out of 507 companies in the Healthcare Providers & Services industry, which is above the industry midpoint.
How does IMAC Holdings' 3-Year EPS without NRI Growth Rate compare to MSPR and HCA?
According to the Healthcare Providers & Services industry distribution chart, IMAC Holdings ranks #171 out of 507 companies for 3-Year EPS without NRI Growth Rate. This puts IMAC Holdings in the upper half of its industry. The industry median 3-Year EPS without NRI Growth Rate is 11.30. IMAC Holdings' value of 24.40% is 115.9% above this benchmark. While the company's 10-year median is 10.60 vs. the industry median of 11.30, IMAC Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EPS without NRI Growth Rate for a Healthcare Providers & Services company?
The median 3-Year EPS without NRI Growth Rate among Healthcare Providers & Services companies is 11.30, based on 507 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EPS without NRI Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EPS without NRI Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. IMAC Holdings's current 3-Year EPS without NRI Growth Rate of 24.40% is 115.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EPS without NRI Growth Rate mean?
A high 3-Year EPS without NRI Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for IMAC Holdings and its competitors. For the Healthcare Providers & Services industry, the median 3-Year EPS without NRI Growth Rate is 11.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IMAC Holdings's current 3-Year EPS without NRI Growth Rate is 24.40%, which is 130% above median its own 10-year median of 10.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IMAC Holdings stock overvalued right now?
IMAC Holdings (BACK) has a current 3-Year EPS without NRI Growth Rate of 24.40%. The current 3-Year EPS without NRI Growth Rate is 24.40%, which is 130% above median its 10-year median of 10.60 and 115.9% above the Healthcare Providers & Services industry median of 11.30. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EPS without NRI Growth Rate calculated?
3-Year EPS without NRI Growth Rate is calculated from a company's financial statements. For IMAC Holdings (BACK), the current 3-Year EPS without NRI Growth Rate is 24.40% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
IMAC Holdings Inc is engaged in providing services related to proteomic products that identify and support oncology clinical treatment decisions and biopharmaceutical drug development. The Company has determined that it currently operates in a single segment, precision medicine in cancer treatment, located in a single geographic location, the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BACK has been successfully added to your 
